Tradition and innovation in development of a Zika vaccine

dc.creatorMarques, Ernesto T. A.
dc.creatorBurke, Donald S.
dc.date2019-05-22T13:57:55Z
dc.date2019-05-22T13:57:55Z
dc.date2018
dc.date.accessioned2023-09-26T23:02:32Z
dc.date.available2023-09-26T23:02:32Z
dc.identifierMARQUES, Ernesto T. A.; BURKE, Donald S. Tradition and innovation in development of a Zika vaccine. The Lancet, v. 391, p. 516–517, 10 Feb. 2018.
dc.identifier1474-547X
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/33175
dc.identifier10.1016/S0140-6736(17)33107-0
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8886163
dc.descriptionComment on Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.
dc.description2050-01-01
dc.formatapplication/pdf
dc.languageeng
dc.rightsrestricted access
dc.subjectViral Vaccines
dc.subjectZika Virus
dc.subjectHumans
dc.subjectHumanos
dc.subjectVacinas
dc.subjectVacinas virais / imunologia
dc.subjectZika Virus / imunologia
dc.subjectInfecção por zika vírus / imunologia
dc.titleTradition and innovation in development of a Zika vaccine
dc.typeArticle


Este ítem pertenece a la siguiente institución